期刊文献+

表皮生长因子受体和血管内皮生长因子在胃近端癌组织中的表达 被引量:2

Expression of epidermal growth factor receptor and vascular endothelial growth factor in proximal gastric carcinoma
下载PDF
导出
摘要 目的检测表皮生长因子受体(EGFR)和血管内皮生长因子(VEGF)分别在胃贲门部和胃窦部癌组织中的表达情况,了解胃贲门癌和胃窦癌的生物学特性及不良预后的原因,指导胃癌术后的治疗。方法选取手术切除的胃贲门癌组织标本64例和胃窦癌组织标本67例,常规病理检查,应用链霉菌亲生物素蛋白-过氧化物酶连接(S-P)免疫组化法检测癌组织中EGFR和VEGF蛋白表达,比较两组患者3年生存率。结果胃贲门癌组EGFR和VEGF蛋白表达率高于胃窦癌组(P<0.05)。胃贲门癌组患者3年生存率差于胃窦癌组(P<0.05)。结论胃贲门部癌组织中的EGFR和VEGF基因蛋白过度表达,与胃贲门部癌生物学行为差、预后不良存在着密切关系,反映了贲门癌有较高复发和转移危险,提示有加强贲门癌手术后辅助治疗的必要性。 Objective To detect the expressions of epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) in gastric carcinomas and to investigate the biological features and prognostic factors of antral and cardiac gastric carcinomas. Methods All patients were divided into cardiac carcinoma group (n=64) and antral carcinoma group (n=67). The expressions of VEGF and EGFR were detected by streptavidin-peroxidase immunohistochemistry. All data were statistically analyzed. Results When compared with antral carcinoma group, VEGF and EGFR were significantly increased in cardiac gastric carcinoma group (P 〈0.05). The survival rate was significantly lower in cardiac gastric carcinoma group than in antral gastric carcinoma group (P 〈0.05). Conclusion Over-expressions of VEGF and EGFR in cardiac gastric carcinoma may closely connect with its higher risks of recurrence and metastasis.
作者 乔蕾 董信春
出处 《兰州大学学报(医学版)》 CAS 2009年第1期9-10,14,共3页 Journal of Lanzhou University(Medical Sciences)
基金 甘肃省科学事业费(QS031-C33-11)
关键词 胃贲门癌 表皮生长因子受体 血管内皮生长因子 cardiac gastric carcinoma epidermal growth factor receptor vascular endothelial growth factor
  • 相关文献

参考文献8

  • 1金晓明,孔祥冰,孙宇,松井一裕,北川正信,李凯.贲门部浸润性癌预后的探讨[J].哈尔滨医科大学学报,2000,34(3):157-159. 被引量:1
  • 2Al-KASSPOOLES M,MOORE J H,ORRINGER M B.et al.Amplification and over-expression of the EGFR and ErbB2 genes in human esophageal adenocarcinomas[J].Int J Cancer,1993,54(2):213-219.
  • 3李敏,陈健,蒋敏,骞爱荣,赵俊生.c-erbB-2、VEGF和组织蛋白酶D在胃癌中的表达及其相关性[J].临床与实验病理学杂志,2002,18(1):65-68. 被引量:8
  • 4YARDEN Y,SLIWKOWSKI M X.Untangling the ErbB signaling network[J].Nat Rev Mol Biol,2001,2(2):127-137.
  • 5KLAPPER L N,KIRSCHBAUM M A,SELA M,et al.Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors[J].Adv Cancer Re8,2000,77(10):25-29.
  • 6周琦,白永敏,刘宾,贺新伟,范宗民,李吉林,高珊珊,郭花芹,王道存,常志伟,易会兴,王宁博,王立东.贲门癌高、低发区居民贲门癌前病变和癌组织表皮生长因子受体检测[J].郑州大学学报(医学版),2003,38(3):332-334. 被引量:2
  • 7MINATO E,MIKI C.Vascular endothelial growth factor as an age-dependent prognostic factor in gastric cancer patients[J].Am J Surg,2002,184(5):460-464.
  • 8FOLKMAN J.Role of angiogenesis in tumor growth and metastasis[J].Semin Oncol,2002,29(6 Suppl 16):15-18.

二级参考文献9

  • 1万因森.C-erbB-2/neu基因表达水平与结直肠癌预后的关系[J].中山医科大学学报,1994,15(2):120-124. 被引量:9
  • 2陈艺华,董敬朋,李春德,陆药丹,张盛.人乳腺癌c-erbB2基因扩增及过度表达的研究[J].中华肿瘤杂志,1995,17(1):16-19. 被引量:23
  • 3王立东,周琦,李永欣,邢莹,刘保池,裘宋良,Susan Goldstein,Stephenie T Shi,Jun Y.Hong,Chung S.Yang.食管和贲门癌前病变癌基因c-erbB_2、c-myc和cyclin D_1的表达研究[J].河南医科大学学报,1995,30(2):146-149. 被引量:7
  • 4山际裕史 马玉峰.胃的肠上皮化生及分化型腺癌EGF,EGFR,PCNA,c-erbB-2,p53,K-ras的免疫组化染色研究[J].国外医学:分子生物学分册,1994,16:283-283.
  • 5Gianion D, Massimo L, Michele P. Cell cycle and cancer:Critical events at G1 restriction point. Crit Rev Carcinog,1996, 7(1) :127.
  • 6Gullick WJ. Prevalence of abrrant expression of the epidermal growth factor receptor in human cancers. Br. Med.Bull, 1991,47(1) :87.
  • 7Salomon DS, Brandt R, Ciardiello F, et al. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol, 1995,19 ( 3 ) : 183.
  • 8Wang LD, Stephanie TS, Zhou Q, et al. Changes in p53 and Cyclin D1 protein levels and cell proliferation in different stages of esophageal and gastric cardia carcinogenesis. Int J Cancer, 1994, 59(4) :514.
  • 9Wang L S,Cancer,1993年,76卷,1948页

共引文献8

同被引文献19

  • 1曹更生,柳爱莲,李宁.隐藏在基因组中的遗传信息[J].遗传,2004,26(5):714-720. 被引量:8
  • 2田军,王跃建,王天铎,李学忠,苏振忠.基质金属蛋白酶与下咽癌侵袭转移的相关性研究[J].山东大学基础医学院学报,2005,19(4):212-214. 被引量:1
  • 3金惠铭,卢建,殷莲华.分子病理生理学[M].郑州:郑州大学出版社,2002.
  • 4谷志远,赵亚力.医学分子生物学[M].北京:人民军医出版社,2002.
  • 5Hinestrosa MC,Dickersin K,Klein P,et al.Shapingthe future of biomarker research in breast cancer to en-sure relevance[J].Nature Reviews Cancer,2007,7:311-315.
  • 6Tavassoli FA,Devilee P.World Health Organizationclassification of tumours:pathology and genetics oftumours of the breast and female genital organs[M].Lyon:IARC Press,2003.
  • 7Burnside ES,Sickles EA,Bassett LW,et al.The ACRBI2RADS experience:learning from history[J].Journalof the American College of Radiology,2009,6(12):851-860.
  • 8Liakakos T,Xeropotamos N,Ziogas D.EGFR as aprognostic marker for gastric cancer[J].World J Surg,2008,32(6):1225-1226.
  • 9Ciardiello F,Tortora G.EGFR antagonists in cancertreatment[J].N Engl J Med,2008,358(11):1160-1174.
  • 10李梅,曹学全,陈奎生.组织蛋白酶B表达与宫颈鳞癌浸润转移的关系[J].河南医学研究,2007,16(3):197-199. 被引量:1

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部